Natixis Advisors, L.P. Artivion, Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Artivion, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 10,838 shares of AORT stock, worth $326,657. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,838Holding current value
$326,657% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
176Shares Held
37.1MCall Options Held
20.5KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$84.5 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$84.2 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$82.5 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$71.1 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.22B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...